Company · CIK 0000874716 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq
IDEXX LABORATORIES INC /DE · IDXX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 SForm 4 → | Sep 9, 5:00 pm EDT | Lawrence D KingsleyDirector | 2,203 | $532.08 | $1,172,178 | 9,568 | −18.7% | |
| Sep 4, 2026 MForm 4 → | Sep 9, 5:00 pm EDT | Lawrence D KingsleyDirector | 2,203 | $114.17 | $251,517 | 11,771 | — | |
| Aug 20, 2026 FMForm 4 → | Aug 24, 5:00 pm EDT | Andrew EmersonEVP, CFO and Treasurer | 351 | $178.26 | $47,239 | 4,421 | — | |
| Jul 30, 2026 AForm 4 → | Aug 3, 5:00 pm EDT | Joseph L HooleyDirector | 49 | $558.80 | $27,381 | 325 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 MForm 4 → | Sep 9, 5:00 pm EDT | Lawrence D KingsleyDirector | 2,203 | — | — | 0 | — | |
| Aug 20, 2026 MForm 4 → | Aug 24, 5:00 pm EDT | Andrew EmersonEVP, CFO and Treasurer | 265 | — | — | 925 | — |